Categories: News

Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) — Option Care Health, Inc. (the “Company” or “Option Care Health”)(Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements. Dr. Kumbhat will also focus on optimizing clinical operations to ensure the Company delivers the highest quality standards, superior clinical outcomes and a highly satisfying patient experience.

Prior to joining Option Care Health, Dr. Kumbhat served as Senior Vice President and Regional Medical Officer for Fresenius Kabi. Over her accomplished career, she held relevant roles at Hospira, McKesson, GE Healthcare and Epic Systems. She earned her Doctor of Medicine from the University of Miami Medical School, completed her surgical internship at Northwestern Medical Center and did residency training in surgery at the University of Wisconsin Hospital and Clinics. She joins our team of nearly 2,900 clinicians that have dedicated themselves to providing extraordinary care that changes lives.

“As we continue to invest in our clinical differentiation and set the standard for delivering care to patients requiring infusion therapy in the alternate site setting, I am thrilled to have Dr. Kumbhat join our leadership team and help drive our clinical strategy going forward. As a physician, she brings a wealth of knowledge to the Option Care Health team, and I’m confident she will make a positive impact in continuing efforts to elevate patient care”, John Rademacher, Chief Executive Officer, commented.

About Option Care Health

Option Care Health is the nation’s largest independent provider of home and alternate site infusion services. With over 5,000 teammates, including approximately 2,900 clinicians, we work compassionately to elevate standards of care for patients with acute and chronic conditions in all 50 states. Through our clinical leadership, expertise and national scale, Option Care Health is reimagining the infusion care experience for patients, customers and teammates.

Investor Contacts
   
Mike Shapiro
Chief Financial Officer
T: (312) 940-2538
mike.shapiro@optioncare.com 
Bob East, Asher Dewhurst, Jordan Kohnstam
Westwicke
T: (413) 213-0500
optioncarehealth@westwicke.com 

Staff

Recent Posts

Advanced Medical Balloons announces its new hygh-tec Odor Solution™ product, broadening its catheter portfolio

hygh-tec Odor Solution™ will be launched in Q2 2025FDA clearance and MDR certification already securedFirst generation…

2 hours ago

Survey Projects High Turnover Rates Among Healthcare Executives in 2025

46% Plan to Leave Their Organizations in the Next 12 MonthsDALLAS, March 24, 2025 (GLOBE…

2 hours ago

PharmAla Contracts with Partner to Act as US Distributor

TORONTO, March 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…

2 hours ago

PathAI Expands AISight® Digital Pathology Adoption with Four New Laboratory Partners

BOSTON, March 24, 2025 (GLOBE NEWSWIRE) -- PathAI, a global leader in AI-powered pathology, is…

2 hours ago

Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases   

Company prioritizes ophthalmology pipeline programs with potential to provide new or improved treatment options in…

2 hours ago

Can-Fite Initiates Pivotal Phase 3 Psoriasis Study of its Oral Drug Piclidenoson with FDA & EMA-Approved Protocol

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to…

2 hours ago